The prevalence and the risk factors associated with tranquilizer abuse in the population with the age of over 18 years in Iran
DOI:
https://doi.org/10.22122/cdj.v6i1.251Keywords:
Substance Abuse, Pain, Chronic Pain, DrugsAbstract
BACKGROUND: Non-medical use of prescription drugs is a growing global health concern. The real scale of the problem is unknown. Statistics indicate that taking painkillers and sedatives leads to dependency and addiction to the drugs administered. Therefore, this study aimed to determine the prevalence and risk factors of drug abuse for causing lethargy and sedation in the population with the age of over 18 years in Sanandaj City, Iran.
METHODS: This descriptive-analytic study was conducted in year 2015. The sample size was 1750 people, and cluster sampling method was performed from all health care centers in Sanandaj City. Data were collected using a researcher-made questionnaire to assess intractable consumption and tranquilizer drug abuse, and addiction to these medications. Data were analyzed using chi-square test and logistic regression analysis to identify socio-demographic and risk behavior correlated with abuse tranquilizer or sedative drugs.
RESULTS: 80% of the participants had intractable consumption, and 18% of those with intractable consumption had dependency to these drugs (having two symptoms of withdrawal and denial of medications according to DSM-IV). The factors affecting consumption and drug abuse can be arbitrary, job, availability of pharmaceuticals, insurance, family history of addiction, marital status, physical or mental illness, and conflict in the family.
CONCLUSION: Dependency to lethargy-inducing drugs and tranquilizers was high in the study population. So, planning to make people aware of the consequences of taking drugs, especially tranquilizers and lethargy-inducing drugs, is very important.
References
McCabe SE, Teter CJ, Boyd CJ. Medical use, illicit use, and diversion of abusable prescription drugs. J Am Coll Health 2006; 54(5): 269-78.
Bollinger LC, Bush C, Chenault KI, Lee Curtis J, Dimon J, Dolan J, et al. Under the counter: the diversion and abuse of controlled prescription drugs in the U.S [Online]. [cited 2005]; Available from: URL: https://www.centeronaddiction.org/sites/default/files/Under-the-counter-the-diversion-and-abuse-of-controlled-prescription-drugs-in-the-us_0.pdf
Berland-Benhaim C, Giocanti D, Bartoli C, Sastre C, Leonetti G, Pelissier-Alicot A. Medication misuse and abuse: duties and responsibilities of dispensing pharmacists. Med Sci Law 2011; 51(1): 49-55.
Compton WM, Volkow ND. Abuse of prescription drugs and the risk of addiction. Drug Alcohol Depend 2006; 83(Suppl 1): S4-S7.
Blakeslee S. Drug makers hope to kill the kick in pain relief [Online]. [cited 2004]; Available from: URL: https://www.nytimes.com/2004/04/20/science/drug-makers-hope-to-kill-the-kick-in-pain-relief.html
Fischer G, Viglione AM, Calabrese A, Dobbin M, Bertoloti JM, Qianrong W, et al. The non-medical use of prescription drugs. New York, NY: United Nations; 2011.
Asefzadeh S, Anbarloei M, Habibi S, Rezaei M. Self-medication among the in-patients of Qazvin teaching hospitals. J Qazvin Univ Med Sci 2002; 5(4): 48-54. [In Persian].
Martins SS, Fenton MC, Keyes KM, Blanco C, Zhu H, Storr CL. Mood and anxiety disorders and their association with non-medical prescription opioid use and prescription opioid-use disorder: longitudinal evidence from the National Epidemiologic Study on Alcohol and Related Conditions. Psychol Med 2012; 42(6): 1261-72.
Ford JA. Nonmedical prescription drug use among adolescents: the influence of bonds to family and school. Youth Soc 2008; 40(3): 336-52.
Herman-Stahl MA, Krebs CP, Kroutil LA, Heller DC. Risk and protective factors for nonmedical use of prescription stimulants and methamphetamine among adolescents. J Adolesc Health 2006; 39(3): 374-80.
Guo L, Xu Y, Deng J, He Y, Gao X, Li P, et al. Non-medical use of prescription pain relievers among high school students in China: a multilevel analysis. BMJ Open 2015; 5(7): e007569.
Rezahosseini O, Roohbakhsh A, Tavakolian V, Assar S. Drug abuse among university students of Rafsanjan, Iran. Iran J Psychiatry Behav Sci 2014; 8(2): 81-5.
Becker WC, Sullivan LE, Tetrault JM, Desai RA, Fiellin DA. Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates. Drug Alcohol Depend 2008; 94(1-3): 38-47.
Tetrault JM, Desai RA, Becker WC, Fiellin DA, Concato J, Sullivan LE. Gender and non-medical use of prescription opioids: results from a national US survey. Addiction 2008; 103(2): 258-68.
Sung HE, Richter L, Vaughan R, Johnson PB, Thom B. Nonmedical use of prescription opioids among teenagers in the United States: trends and correlates. J Adolesc Health 2005; 37(1): 44-51.
Poulin C. Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use. CMAJ 2001; 165(8): 1039-44.
Movaghar Afarin R, Sharifi V, Mohammadi MR, Farhoudian A, Sahimi Izadian E, Radgoudarzi R, et al. Researches on substance use in Iran; 3 decades evaluation. Hakim Res J 2006; 8(4): 37-44. [In Persian].
Sarrami H, Ghorbami M, Taghavi M. The survey two decades of prevalence studies among iran university students. Journal of Research on Addiction 2013; 7(27): 9-36. [In Persian].
Mohamadi N, Shobeiri F, Mahgoob H. The Prevalence of Substance Abuse in Students of Hamadan University of Medical Sciences. Zahedan J Res Med Sci 2012; 14(1): 86-9. [In Persian].
Sayed Javadi M, Mohammadi R, Ebrahimi Baliai F, Seyed Mousavi E. An epidemiological study of drug abuse in self-introduced addicts to addiction clinic in Ardabil in 2012. Proceedings of the 7th Congress of addiction; 2013 Sep 11-13; Tehran, Iran. [In Persian].
Bali V, Raisch DW, Moffett ML, Khan N. Determinants of nonmedical use, abuse or dependence on prescription drugs, and use of substance abuse treatment. Res Social Adm Pharm 2013; 9(3): 276-87.
Rahimi F, Gharib A, Rafat S. Related factors in medication error based on nurses'self-report in Sanandaj, Iran. Der Pharmacia Lettre 2015; 7(10): 198-201.
Kokkevi A, Stefanis C. Drug abuse and psychiatric comorbidity. Compr Psychiatry 1995; 36(5): 329-37.
Logan DE, Marlatt GA. Harm reduction therapy: A practice-friendly review of research. J Clin Psychol 2010; 66(2): 201-14.
Boyd CJ. The antecedents of women's crack cocaine abuse: family substance abuse, sexual abuse, depression and illicit drug use. J Subst Abuse Treat 1993; 10(5): 433-8.
